31 /100
MEDIUM RISK
Score updated Jul 13, 2026

HIVE — HIVE Digital Technologies Ltd. Dilution Risk Tracker

Track HIVE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HIVE — Get alerts when the score changes →

As of July 13, 2026, HIVE Digital Technologies Ltd. (HIVE) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. HIVE Digital Technologies Ltd. has a market capitalization of $1.14B, 267.43M shares outstanding, 10 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
0
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
🔁 Convertible Conversion 40%
• Significant convertible debt: 27% potential dilution
• Elevated convertible risk (60/100)
🔔 Track HIVE — Get forecast alerts →

💹 Market Data

Market Cap$1.14B
Shares Outstanding267.43M
Float251.16M
Cash$23.11M
Debt$2.04M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 54.48M shares
#1 Invesco Ltd. 13.34M shares
#2 Millennium Management Llc 7.29M shares
#3 Two Sigma Investments, LP 6.09M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest56.03M
Days to Cover1.4
% of Float22.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
4 INSIDER TRANSACTION Jul 10, 2026
4 INSIDER TRANSACTION Jul 10, 2026
4 INSIDER TRANSACTION Jul 02, 2026
4 INSIDER TRANSACTION Jul 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for HIVE Shareholders

HIVE Digital Technologies Ltd. (HIVE) has a DilutionScore of 31/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for HIVE shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HIVE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HIVE alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HIVE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HIVE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HIVE
📊 HIVE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HIVE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.